Fundz

ProSomnus Sleep Technologies, Inc.

Pleasanton, United States · 9 employees

ProSomnus (NASDAQ: OSA) is a leading CPAP alternative for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each

Funding history

  • Funding Round — $38.0M — Feb 2026
  • Funding Round — $10.1M — Oct 2023
  • Funding Round — $10.0M — Sep 2023
  • Series pre-seed — $50K — Aug 2019

Recent signals

  • Feb 18, 2026: Raised $38.0M
  • Oct 02, 2023: Raised $10.1M
  • Sep 21, 2023: Raised $10.0M
  • Aug 20, 2019: Raised $50K in Series pre-seed

See plans & pricing → Track ProSomnus Sleep Technologies, Inc.’s funding, hiring, and signals — with verified contacts — on Fundz.